🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Identification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas

Recruitingn/aAges any - anyAllIstituto Ortopedico Rizzoli
NCT07685405 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study involves blood samples from patients with Ewing's sarcoma to identify circulating biomarkers as a tool for the preclinical validation of innovative therapeutic approaches

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion criteria for cancer patients * Male and female patients of any age diagnosed with Ewing sarcoma. * Signed, study-specific informed consent form for the BIOVES study (cancer patients) Inclusion criteria for non-cancer patients * Male and female patients of legal age without a cancer diagnosis. * Signed, study-specific informed consent form for the BIOVES study (non-cancer patients) Exclusion Criteria: Patients who do not meet all inclusion criteria \-
💊

What it tests

  • one blood sample
  • 3 blood samples
📍

Where

1 site
Istituto ortopedico Rizzoli Laboratorio di Ricerc Oncologica e Genomica funzioanle
Bologna, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy